Catalyst Wire Dossier Catalyst Wire Dossier

FIT-CD19-CAR-T Cells

CAR-T cell therapy targeting CD19 · TriArm Therapeutics (Taiwan) Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FIT-CD19-CAR-T Cells, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL [Phase 1]

See pricing